AEMD : Summary for Aethlon Medical, Inc. - Yahoo Finance

We are experiencing some temporary issues. The market data on this page are currently delayed. Please bear with us as we address this and restore your personalized lists.

U.S. Markets open in 1 hr 5 mins

Aethlon Medical, Inc. (AEMD)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
4.61 -0.49 (-9.59%)
At close: 4:00 PM EST
People also watch:
CTSO AMAR ADXS BKYI IBIO
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close 5.10
Open 0.00
Bid 0.00 x
Ask 5.19 x 300
Day's Range 4.61 - 5.15
52 Week Range 4.02 - 9.09
Volume 18,578
Avg. Volume 25,869
Market Cap 35.18M
Beta 2.69
PE Ratio (TTM) -6.03
EPS (TTM) -0.76
Earnings Date Feb 2, 2017 - Feb 6, 2017
Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Price Target 26.00
Trade prices are not sourced from all markets
  • Capital Cube 20 hours ago

    ETFs with exposure to Aethlon Medical, Inc. : November 16, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Aethlon Medical, Inc. Here are 5 ETFs with the largest exposure to AEMD-US. Comparing the performance and risk of Aethlon Medical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Aethlon Medical, Inc. :AEMD-US: Earnings Analysis: Q2, 2017 By the Numbers : November 14, 2016
    Capital Cube 3 days ago

    Aethlon Medical, Inc. :AEMD-US: Earnings Analysis: Q2, 2017 By the Numbers : November 14, 2016

    Categories: Yahoo Finance Get free summary analysis Aethlon Medical, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Aethlon Medical, Inc. – Inovio Pharmaceuticals, Inc., Idera Pharmaceuticals, Inc., Coherent, Inc., Bruker Corporation, PerkinElmer, Inc., pSivida Corp., Pacific Biosciences of California, Inc., Accelerate Diagnostics, Inc. and Sparton ... Read more (Read more...)

  • Aethlon Medical, Inc. (AEMD) Approaching A Major Catalyst With Hemopurifier Trial
    Insider Monkey 16 days ago

    Aethlon Medical, Inc. (AEMD) Approaching A Major Catalyst With Hemopurifier Trial

    While biotechs big and small are busy slogging through a years-to-decades long clinical trial process and burning though hundreds of millions on the way, here’s a comforting thought: There currently is no business model anywhere in biotech for dealing with a serious disease outbreak on the fly. Everything is slow in drug development. Extremely slow […]

  • Thomson Reuters StreetEvents 3 months ago

    Edited Transcript of AEMD earnings conference call or presentation 11-Aug-16 8:30pm GMT

    Q1 2017 Aethlon Medical Inc Earnings Call

  • Zacks Small Cap Research 3 months ago

    AEMD: Q1 Results. Add Zika to List of Potential Targets

    Aethlon (AEMD) reported financial results for their first quarter 2017 and provided and operational update.  Financial results were largely inline with our expectations although there was a notable positive variance in operating expenses, reflecting a combination of management's continued diligence on expense control as well as lower than anticipated spend on R&D - the latter which we attribute to slower trajectory to the U.S. feasibility study as compared to what we had been modeling.  But the study is now 50% enrolled and management is still guiding for completion by current year-end. Revenue was just $5k in the quarter - inline with what we had expected, and entirely related to the Battelle subcontract.  AEMD still has almost $400k under the DARPA contract yet to be billed, at least a portion of which we think could be booked in the current quarter (i.e.

  • 24/7 Wall St. 3 months ago

    5 Biohealth Stocks Rising 10% or More on News

    A few biohealth companies made absolutely massive runs in Thursday’s session. The companies 24/7 Wall St. has picked stood out from the rest with big moves, all at least up 10%.

  • Capital Cube 4 months ago

    Aethlon Medical, Inc. :AEMD-US: Earnings Analysis: 2016 By the Numbers : July 26, 2016

    Click here to see latest analysisAethlon Medical, Inc. reports financial results for the year ended March 31, 2016.HighlightsChange in operating cash flow of 14.26% compared to same period last year is about the same as change in earnings, likely no significant movement in accruals or reserves.Earnings decline largely a result of non-operational activity, pretax margins […] (Read more...) The post Aethlon Medical, Inc. :AEMD-US: Earnings Analysis: 2016 By the Numbers : July 26, 2016 appeared first on CapitalCube.

  • Capital Cube 4 months ago

    ETF’s with exposure to Aethlon Medical, Inc. : July 20, 2016

    Click here to see latest analysis*Disclaimer : This is as of previous day’s closeETF’s with exposure to Aethlon Medical, Inc.Here are 5 ETF’s with the largest exposure to AEMD-US. Comparing the performance and risk of Aethlon Medical, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us […] (Read more...) The post ETF’s with exposure to Aethlon Medical, Inc. : July 20, 2016 appeared first on CapitalCube.

  • Aethlon Medical, Inc. :AEMD-US: Earnings Analysis: Q4, 2016 By the Numbers : July 6, 2016
    Capital Cube 4 months ago

    Aethlon Medical, Inc. :AEMD-US: Earnings Analysis: Q4, 2016 By the Numbers : July 6, 2016

    Click here to see latest analysisAethlon Medical, Inc. reports financial results for the quarter ended March 31, 2016.HighlightsSummary numbers: Revenues of USD 0.20 million, Net Earnings of USD -1.25 million.Change in operating cash flow of 40.60% compared to same period last year is about the same as change in earnings, likely no significant movement in […] (Read more...) The post Aethlon Medical, Inc. :AEMD-US: Earnings Analysis: Q4, 2016 By the Numbers : July 6, 2016 appeared first on CapitalCube.

  • Zacks Small Cap Research 4 months ago

    AEMD: U.S. Clinical Trial Progressing, ATM Financing

    By Brian Marckx, CFA NASDAQ:AEMD Fiscal Q4 2016 Financials, Operational Update  Aethlon (NASDAQ:AEMD) reported financial results for their fourth quarter 2016 and provided and operational update.  Financial ...